These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35976880)

  • 21. The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections.
    Zurawski DV; Mumy KL; Badea L; Prentice JA; Hartland EL; McCormick BA; Maurelli AT
    Infect Immun; 2008 Jan; 76(1):369-79. PubMed ID: 17984206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular basis for CesT recognition of type III secretion effectors in enteropathogenic Escherichia coli.
    Little DJ; Coombes BK
    PLoS Pathog; 2018 Aug; 14(8):e1007224. PubMed ID: 30118511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection.
    Serapio-Palacios A; Finlay BB
    Curr Opin Microbiol; 2020 Apr; 54():67-76. PubMed ID: 32058947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The T3SS effector EspT defines a new category of invasive enteropathogenic E. coli (EPEC) which form intracellular actin pedestals.
    Bulgin R; Arbeloa A; Goulding D; Dougan G; Crepin VF; Raymond B; Frankel G
    PLoS Pathog; 2009 Dec; 5(12):e1000683. PubMed ID: 20011125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tir phosphorylation and Nck/N-WASP recruitment by enteropathogenic and enterohaemorrhagic Escherichia coli during ex vivo colonization of human intestinal mucosa is different to cell culture models.
    Schüller S; Chong Y; Lewin J; Kenny B; Frankel G; Phillips AD
    Cell Microbiol; 2007 May; 9(5):1352-64. PubMed ID: 17474908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Serine Protease EspC from Enteropathogenic Escherichia coli Regulates Pore Formation and Cytotoxicity Mediated by the Type III Secretion System.
    Guignot J; Segura A; Tran Van Nhieu G
    PLoS Pathog; 2015 Jul; 11(7):e1005013. PubMed ID: 26132339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of EscU auto-cleavage in promoting type III effector translocation into host cells by enteropathogenic Escherichia coli.
    Thomassin JL; He X; Thomas NA
    BMC Microbiol; 2011 Sep; 11():205. PubMed ID: 21933418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection.
    Hemrajani C; Berger CN; Robinson KS; Marchès O; Mousnier A; Frankel G
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3129-34. PubMed ID: 20133763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Type III Effector NleD from Enteropathogenic Escherichia coli Differentiates between Host Substrates p38 and JNK.
    Creuzburg K; Giogha C; Wong Fok Lung T; Scott NE; Mühlen S; Hartland EL; Pearson JS
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27872241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD).
    Scott NE; Giogha C; Pollock GL; Kennedy CL; Webb AI; Williamson NA; Pearson JS; Hartland EL
    J Biol Chem; 2017 Oct; 292(42):17337-17350. PubMed ID: 28860194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct Roles of the Antiapoptotic Effectors NleB and NleF from Enteropathogenic Escherichia coli.
    Pollock GL; Oates CVL; Giogha C; Wong Fok Lung T; Ong SY; Pearson JS; Hartland EL
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28138023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Translocation Inhibitors Targeting the Type III Secretion System of Enteropathogenic Escherichia coli.
    Mühlen S; Zapol'skii VA; Bilitewski U; Dersch P
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0095821. PubMed ID: 34543097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SepD/SepL-dependent secretion signals of the type III secretion system translocator proteins in enteropathogenic Escherichia coli.
    Deng W; Yu HB; Li Y; Finlay BB
    J Bacteriol; 2015 Apr; 197(7):1263-75. PubMed ID: 25645555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE.
    Vossenkämper A; Marchès O; Fairclough PD; Warnes G; Stagg AJ; Lindsay JO; Evans PC; Luong le A; Croft NM; Naik S; Frankel G; MacDonald TT
    J Immunol; 2010 Oct; 185(7):4118-27. PubMed ID: 20833837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The basolateral vesicle sorting machinery and basolateral proteins are recruited to the site of enteropathogenic E. coli microcolony growth at the apical membrane.
    Pedersen GA; Jensen HH; Schelde AB; Toft C; Pedersen HN; Ulrichsen M; Login FH; Amieva MR; Nejsum LN
    PLoS One; 2017; 12(6):e0179122. PubMed ID: 28636623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tandem tyrosine phosphosites in the Enteropathogenic Escherichia coli chaperone CesT are required for differential type III effector translocation and virulence.
    Runte CS; Jain U; Getz LJ; Secord S; Kuwae A; Abe A; LeBlanc JJ; Stadnyk AW; Kaper JB; Hansen AM; Thomas NA
    Mol Microbiol; 2018 Jun; 108(5):536-550. PubMed ID: 29509331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The secreted effector protein EspZ is essential for virulence of rabbit enteropathogenic Escherichia coli.
    Wilbur JS; Byrd W; Ramamurthy S; Ledvina HE; Khirfan K; Riggs MW; Boedeker EC; Vedantam G; Viswanathan VK
    Infect Immun; 2015 Mar; 83(3):1139-49. PubMed ID: 25561713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enteropathogenic E. coli relies on collaboration between the formin mDia1 and the Arp2/3 complex for actin pedestal biogenesis and maintenance.
    Velle KB; Campellone KG
    PLoS Pathog; 2018 Dec; 14(12):e1007485. PubMed ID: 30550556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A surprising sweetener from enteropathogenic Escherichia coli.
    Pearson JS; Hartland EL
    Gut Microbes; 2014; 5(6):766-9. PubMed ID: 25536377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial and host determinants of MAL activation upon EPEC infection: the roles of Tir, ABRA, and FLRT3.
    Heath RJ; Leong JM; Visegrády B; Machesky LM; Xavier RJ
    PLoS Pathog; 2011 Apr; 7(4):e1001332. PubMed ID: 21490959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.